In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Merck’s current price at $113.87 trades significantly below the high-confidence fair value of $162.81, implying a 43% upside potential. Strong profitability and efficiency contrast with low growth, while Monte Carlo analysis shows wide valuation volatility and a 22.2% downside risk. This indicates notable upside opportunity tempered by high uncertainty.